$ASNS
ACTELIS NETWORKS INC Stock $asns

$asns Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023038739 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.896M	$1.848M	$1.870M
YoY Change	-38.46%	-1.18%	20.65%
Cost Of Revenue	$1.264M	$1.160M	$1.290M
YoY Change	9.06%	-10.08%	57.7%
Gross Profit	$632.0K	$688.0K	$582.0K
YoY Change	-67.12%	18.21%	-20.05%
Gross Profit Margin	33.33%	37.23%	31.12%
Selling, General & Admin	$1.681M	$1.794M	$1.360M
YoY Change	-11.71%	31.91%	85.54%
% of Gross Profit	265.98%	260.76%	233.68%
Research & Development	$669.0K	$757.0K	$650.0K
YoY Change	-1.04%	16.46%	4.84%
% of Gross Profit	105.85%	110.03%	111.68%
Depreciation & Amortization	$6.000K	$7.000K	-$2.000K
YoY Change	-40.0%	-450.0%	-116.67%
% of Gross Profit	0.95%	1.02%	-0.34%
Operating Expenses	$2.350M	$2.551M	$2.117M
YoY Change	-8.91%	20.5%	50.57%
Operating Profit	-$1.718M	-$1.863M	-$1.535M
YoY Change	161.09%	21.37%	126.4%
Interest Expense	$171.0K	$180.0K	$107.0K
YoY Change	-117.17%	68.22%	98.15%
% of Operating Profit
Other Income/Expense, Net	$296.0K	$148.0K	-$3.210M
YoY Change	-129.72%	-104.61%	-6044.44%
Pretax Income	-$1.593M	-$1.895M	-$4.640M
YoY Change	-3.69%	-59.16%	583.36%
Income Tax
% Of Pretax Income
Net Earnings	-$1.593M	-$1.895M	-$4.639M
YoY Change	-3.69%	-59.15%	583.21%
Net Earnings / Revenue	-84.02%	-102.54%	-248.07%
Basic Earnings Per Share	-$0.68	-$1.09	-$22.60
Diluted Earnings Per Share	-$0.68	-$1.09	-$2.263M
COMMON SHARES
Basic Shares Outstanding	1.942M shares	17.41M shares	205.2K shares
Diluted Shares Outstanding	2.333M shares	1.734M shares	205.2K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.382M	$1.618M	$606.0K
YoY Change	-72.63%	167.0%
Cash & Equivalents	$2.573M	$808.0K	$344.0K
Short-Term Investments	$809.0K	$810.0K	$262.0K
Other Short-Term Assets	$924.0K	$1.193M	$1.045M
YoY Change	-51.45%	14.16%
Inventory	$1.808M	$1.274M	$931.0K
Prepaid Expenses
Receivables	$1.759M	$2.473M	$1.330M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.873M	$6.558M	$3.920M
YoY Change	-56.92%	67.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$70.00K	$76.00K	$976.0K
YoY Change	-29.29%	-92.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.631M	$5.367M	$436.0K
YoY Change	375.99%	1130.96%
Total Long-Term Assets	$5.701M	$5.443M	$1.410M
YoY Change	344.7%	286.03%
TOTAL ASSETS
Total Short-Term Assets	$7.873M	$6.558M	$3.920M
Total Long-Term Assets	$5.701M	$5.443M	$1.410M
Total Assets	$13.57M	$12.00M	$5.330M
YoY Change	-30.6%	125.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.918M	$1.400M	$1.540M
YoY Change	15.61%	-9.09%
Accrued Expenses	$2.302M	$2.389M	$2.590M
YoY Change	13.85%	-7.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.223M	$1.206M	$7.270M
YoY Change	59.24%	-83.41%
Total Short-Term Liabilities	$6.716M	$6.372M	$12.19M
YoY Change	3.69%	-47.73%
LONG-TERM LIABILITIES
Long-Term Debt	$3.456M	$3.712M	$8.080M
YoY Change	-24.28%	-54.06%
Other Long-Term Liabilities	$32.00K	$33.00K	-$8.170M
YoY Change	-47.54%	-100.4%
Total Long-Term Liabilities	$5.469M	$4.214M	-$90.00K
YoY Change	2.7%	-4782.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.716M	$6.372M	$12.19M
Total Long-Term Liabilities	$5.469M	$4.214M	-$90.00K
Total Liabilities	$12.19M	$10.59M	$23.96M
YoY Change	3.25%	-55.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.89M	-$35.30M
YoY Change	28.48%
Common Stock	$1.000K	$1.000K	$0.00
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.285M	$1.415M	-$24.22M
YoY Change
Total Liabilities & Shareholders Equity	$13.57M	$12.00M	$5.330M
YoY Change	-30.6%	125.16%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.593M	-$1.895M	-$4.639M
YoY Change	-3.69%	-59.15%	583.21%
Depreciation, Depletion And Amortization	$6.000K	$7.000K	-$2.000K
YoY Change	-40.0%	-450.0%	-116.67%
Cash From Operating Activities	-$1.234M	-$1.705M	-$504.0K
YoY Change	-50.14%	238.29%	-37.24%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$3.000K	-$13.00K
YoY Change	-100.0%	-123.08%	550.0%
Acquisitions
YoY Change
Other Investing Activities	$1.011M	-$331.0K	-$262.0K
YoY Change	429.32%	26.34%
Cash From Investing Activities	$1.011M	-$334.0K	-$275.0K
YoY Change	432.11%	21.45%	13650.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$192.0K	$129.0K
YoY Change		48.84%
Cash From Financing Activities	3.022M	-$242.0K	-272.0K
YoY Change	-79.16%	-11.03%	-113.67%
NET CHANGE
Cash From Operating Activities	-1.234M	-$1.705M	-504.0K
Cash From Investing Activities	1.011M	-$334.0K	-275.0K
Cash From Financing Activities	3.022M	-$242.0K	-272.0K
Net Change In Cash	2.799M	-$2.281M	-1.051M
YoY Change	-77.09%	117.03%	-188.69%
FREE CASH FLOW
Cash From Operating Activities	-$1.234M	-$1.705M	-$504.0K
Capital Expenditures	$0.00	$3.000K	-$13.00K
Free Cash Flow	-$1.234M	-$1.708M	-$491.0K
YoY Change	-50.12%	247.86%	-38.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.09
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41375
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2160309
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4039 Clipper Court
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Fremont
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94538
CY2023Q1	dei	City Area Code CityAreaCode	(510)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	545-1045
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	ASNS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1942323	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	808000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3943000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	810000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	1622000	usd
CY2023Q1	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	780000	usd
CY2022Q4	us-gaap	Other Restricted Assets Current OtherRestrictedAssetsCurrent	451000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1734160	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	156000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	125000	usd
CY2023Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	2473000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3034000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1274000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1179000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	413000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	678000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	6558000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	10907000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	80000	usd
CY2023Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	492000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	492000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1190000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	336000	usd
CY2023Q1	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	2889000	usd
CY2022Q4	us-gaap	Other Restricted Assets Noncurrent OtherRestrictedAssetsNoncurrent	2027000	usd
CY2023Q1	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	233000	usd
CY2022Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	239000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	548000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	726000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	12000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	5443000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	3912000	usd
CY2023Q1	us-gaap	Assets Assets	12001000	usd
CY2022Q4	us-gaap	Assets Assets	14819000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1206000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	553000	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1400000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1781000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	574000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	484000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	795000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	793000	usd
CY2023Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	931000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	900000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	361000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	445000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1097000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1238000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6372000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6202000	usd
CY2023Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	3712000	usd
CY2022Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	4625000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	39000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	164000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	159000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	237000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	271000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	278000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4214000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	5352000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	10586000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11554000	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1730066	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1730066	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1737986	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1737986	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2022Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	2803774	shares
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36711000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36666000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35297000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33402000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1415000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12001000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14819000	usd
CY2023Q1	us-gaap	Revenues Revenues	1848000	usd
CY2022Q1	us-gaap	Revenues Revenues	1868000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1160000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1286000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	688000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	582000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	865000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	635000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	757000	usd
CY2022Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	650000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	929000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	730000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2551000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2015000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1863000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1433000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	180000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	220000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	148000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2986000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4639000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-22.6
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1734160	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	205213	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-19596000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4639000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-24221000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3265000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	95000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	50000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1415000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1895000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4639000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	7000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	10000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1058000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	7000	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	43000	usd
CY2023Q1	asns	Exchange Rate Differences ExchangeRateDifferences	-130000	usd
CY2022Q1	asns	Exchange Rate Differences ExchangeRateDifferences	-197000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	95000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	14000	usd
CY2022Q1	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan	966000	usd
CY2022Q1	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote	1075000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	51000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-561000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-813000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-16000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	77000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-265000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	161000	usd
CY2023Q1	asns	Changes In Fair Value Related To Convertible Loan ChangesInFairValueRelatedToConvertibleLoan		usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-381000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-375000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-35000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-61000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-46000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	247000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-16000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-13000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1705000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1307000	usd
CY2023Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	812000	usd
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-262000	usd
CY2023Q1	asns	Short Term Restricted Bank Deposits ShortTermRestrictedBankDeposits	-329000	usd
CY2023Q1	asns	Long Term Restricted Bank Deposits LongTermRestrictedBankDeposits	-811000	usd
CY2023Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	3000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-334000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-277000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1847000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	192000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	129000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-242000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1718000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-5000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-197000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2281000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	134000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4279000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	795000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1998000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	929000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	808000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	344000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	486000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1190000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	99000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1998000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	929000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	116000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	220000	usd
CY2021Q4	us-gaap	Lines Of Credit Fair Value Disclosure LinesOfCreditFairValueDisclosure	2000000	usd
CY2023Q1	asns	Incurred Losses IncurredLosses	1895000	usd
CY2022	asns	Incurred Losses IncurredLosses	10982000	usd
CY2023Q1	asns	Negative Cash Flows From Operations NegativeCashFlowsFromOperations	1705000	usd
CY2022	asns	Negative Cash Flows From Operations NegativeCashFlowsFromOperations	7768000	usd
CY2023Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	35297000	usd
CY2023Q1	asns	Changes In Fair Value Related To Convertible Note ChangesInFairValueRelatedToConvertibleNote		usd
CY2023Q1	us-gaap	Dividends Cash DividendsCash	2398000	usd
CY2023Q1	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	4079000	usd
CY2022Q2	us-gaap	Shares Issued SharesIssued	421250	shares
CY2022Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	46250	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	40
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	15400000	usd
CY2023Q1	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	1000000	usd
CY2023Q1	asns	Warrants Exercisable Price WarrantsExercisablePrice	29487	shares
CY2023Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	50
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	145000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.54	pure
CY2023Q1	asns	Riskfree Rate RiskfreeRate	0.0301	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	19.5
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	178377	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-size: 10pt">b)</span></td><td><b>Use of estimates in preparation of financial statements </b></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-indent: -0.25in"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, fair values of financial instruments, inventory write-offs, as well as in estimates used in applying the revenue recognition policy. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.95in; text-align: justify; text-indent: 0in"> </p>
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1450000	usd
CY2023Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	8000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	8000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of risk</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, and trade receivables. Cash and cash equivalents and restricted cash are placed with banks and financial institutions in the United States and Israel.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, present minimal credit risk with respect to those investments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s trade receivables are derived primarily from telecommunication operators, the Company’s reseller customers and enterprises located mainly in the United States, Europe, and Asia.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk with respect to trade receivables exists to the full extent of the amounts presented in the consolidated financial statements. Management makes judgments as to its ability to collect outstanding accounts receivable and provides allowances for the applicable portion of accounts receivable when collection becomes doubtful.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management provides allowances based upon a specific review of all significant outstanding invoices, analysis of its historical collection experience, and current economic trends. If the historical data used to calculate the allowance for doubtful accounts does not reflect the Company’s future ability to collect outstanding accounts receivable, additional provisions for doubtful accounts may be needed, and the future results of operations could be materially affected.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0in">The Company has major customers, representing as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer A represented 29% of the Company Trade receivables balance as of March 31, 2023 and December 31, 2022, respectively.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer B represented 28% and 23% of the Company Trade receivables balance as of March 31, 2023 and December 31, 2022, respectively.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify; font-size: 10pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Customer C represented 0% and 10% of the Company Trade receivables balance as of March 31, 2023 and December 31, 2022, respectively.</p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">See note 13 for details regarding the revenues from these customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Company does not see any credit risk regarding the trade receivable balance, as most of the remaining balance was paid off after the balance sheet date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	640000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	593000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	634000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	586000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	1274000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1179000	usd
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	147000	usd
CY2022Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-09-30
CY2023Q1	asns	Sublease End Date SubleaseEndDate	2024-03-31
CY2023Q1	us-gaap	Lease Income LeaseIncome	48000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	548000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	726000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	361000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	445000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	159000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	237000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	520000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	682000	usd
CY2020Q4	asns	New Loan NewLoan	6000000	usd
CY2020Q4	us-gaap	Financing Receivable Loan In Process FinancingReceivableLoanInProcess	3000000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	210000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	161000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y5M8D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y6M3D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.025	pure
CY2023Q1	asns	Fixed Payments FixedPayments	182000	usd
CY2022Q1	asns	Fixed Payments FixedPayments	158000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	28000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	3000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	210000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	161000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	299000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	476000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	177000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	177000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	70000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	70000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	546000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	723000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	26000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	41000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	520000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	682000	usd
CY2020Q3	us-gaap	Amount Of Regulatory Assistance Received1 AmountOfRegulatoryAssistanceReceived1	150000	usd
CY2020Q3	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.0375	pure
CY2020Q4	asns	New Loan NewLoan	20000000	ils
CY2021Q1	asns	Additional Loan Value AdditionalLoanValue	2000000	usd
CY2023Q1	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.096	pure
CY2023Q1	asns	Adjustment Of Warrants Granted For Service AdjustmentOfWarrantsGrantedForService	1500000	usd
CY2021Q4	us-gaap	Investment Company Increase From Payment By Affiliate And Gain Loss From Investment In Violation InvestmentCompanyIncreaseFromPaymentByAffiliateAndGainLossFromInvestmentInViolation	1000000	usd
CY2021Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.096	pure
CY2023Q1	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1	1800000	usd
CY2023Q1	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Outstanding Balance CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesOutstandingBalance	4758000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1198000	usd
CY2023Q1	asns	Loan Agreement Value loanAgreementValue	2000000	usd
CY2023Q1	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	2000000	usd
CY2023Q1	asns	Lessee Operating Lease Liability Payments Due1 Year LesseeOperatingLeaseLiabilityPaymentsDue1Year	6000	ils
CY2023Q1	asns	Lessee Operating Lease Liability Payments Due Two Year LesseeOperatingLeaseLiabilityPaymentsDueTwoYear	9000	ils
CY2023Q1	asns	Lessee Operating Lease Liability Payments Due Three Year LesseeOperatingLeaseLiabilityPaymentsDueThreeYear	9000	ils
CY2023Q1	asns	Lessee Operating Lease Liability Payments Due Four Year LesseeOperatingLeaseLiabilityPaymentsDueFourYear	9000	ils
CY2023Q1	asns	Lessee Operating Lease Liability Payments Due Five Year LesseeOperatingLeaseLiabilityPaymentsDueFiveYear	9000	ils
CY2023Q1	asns	Lessee Operating Lease Liability Payments After Year Five LesseeOperatingLeaseLiabilityPaymentsAfterYearFive	129000	ils
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-12000	ils
CY2023Q1	asns	Total Loans Payments TotalLoansPayments	159000	ils
CY2023Q1	asns	Exchange Rate ExchangeRate	1
CY2023Q1	asns	Exchange Rate ExchangeRate	3.615
	asns	Convertible Note Offering Amount ConvertibleNoteOfferingAmount	3000000	usd
	asns	Convertible Note Offering Percentage ConvertibleNoteOfferingPercentage	0.06	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
CY2022Q1	asns	Convertible Note Offered ConvertibleNoteOffered	3000000	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	usd
CY2023Q1	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40	pure
CY2023Q1	asns	Convertible Note Description ConvertibleNoteDescription	The Notes had an optional conversion price at a 40% discount based on a $50m value in the event that an IPO is not consummated and if an IPO is not consummated within 18 months of the issuance of the Notes, the value of the Notes would be set at 110% of their then balance.
CY2022	asns	Addition Addition	1847000	usd
CY2022	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	1753000	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	3600000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	0	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	1075000	usd
CY2017Q1	asns	Aggregrate Principal Amount AggregratePrincipalAmount	2000000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4905	usd
CY2022	asns	Change In Fair Value Reported In Statement Of Comprehensive Loss ChangeInFairValueReportedInStatementOfComprehensiveLoss	1648	usd
CY2022	asns	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	6553	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	996000	usd
CY2016Q3	us-gaap	Shares Issued SharesIssued	7305	shares
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2021Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	2149000	usd
CY2022	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	1049000	usd
CY2022Q4	asns	Conversion To The Companys Common Stock ConversionToTheCompanysCommonStock	-3190000	usd
CY2023Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2022Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	8000	usd
CY2023Q1	asns	Other Financial Expensesincome OtherFinancialExpensesincome	0	usd
CY2022Q1	asns	Other Financial Expensesincome OtherFinancialExpensesincome	1058	usd
CY2023Q1	us-gaap	Credit Derivative Liquidation Proceeds Percentage CreditDerivativeLiquidationProceedsPercentage	1	pure
CY2023Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	14300	usd
CY2023Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	15500	usd
CY2023Q1	us-gaap	Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements	10000	usd
CY2022	asns	Paid Amount PaidAmount	221	usd
CY2023Q1	us-gaap	Servicing Liability ServicingLiability	931	usd
CY2022Q4	us-gaap	Servicing Liability ServicingLiability	900	usd
CY2022Q2	asns	Total Authorized Shares TotalAuthorizedShares	42803774	shares
CY2022Q2	asns	Non Voting Common Stock NonVotingCommonStock	2803774	shares
CY2022Q2	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	10000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	7920	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	7920	shares
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	50000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	10690	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	10690	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96458	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.89
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M2D
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	435	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	40
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96023	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.7
CY2023Q1	asns	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P5Y1M13D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	79076	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.1
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M19D
CY2022Q1	asns	Share Based Compensation Arrangement By Outstanding Numbers ShareBasedCompensationArrangementByOutstandingNumbers	59200	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	16.2
CY2023	asns	Share Based Compensation Arrangement By Forfeited ShareBasedCompensationArrangementByForfeited	-1200	shares
CY2023Q1	asns	Share Based Compensation Arrangement By Outstanding Numbers ShareBasedCompensationArrangementByOutstandingNumbers	58000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	16.2
CY2023Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	96023
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	87317
CY2023Q1	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	4.7	shares
CY2022Q1	us-gaap	Option Indexed To Issuers Equity Shares OptionIndexedToIssuersEquityShares	1.516	shares
CY2023Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	59200	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	16.2
CY2022Q1	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	773108	shares
CY2022Q1	asns	Redeemable Preferred Stock Outstanding RedeemablePreferredStockOutstanding	25624	usd
CY2023Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q1	asns	Revenue From Related Parties Amount RevenueFromRelatedPartiesAmount	1848000	usd
CY2022Q1	asns	Revenue From Related Parties Amount RevenueFromRelatedPartiesAmount	1868000	usd
CY2023Q1	asns	Schedule Of Revenues From Contract Liability ScheduleOfRevenuesFromContractLiability	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding: 0pt; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">March 31,<br/> 2023</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td> <td colspan="2" style="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; text-indent: 0pt">December 31, 2022</td><td style="padding: 0pt; font-weight: bold; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt; width: 76%; text-align: left; text-indent: 0pt">Opening balance</td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">648</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; width: 1%; text-indent: 0pt"> </td> <td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; width: 9%; text-align: right; text-indent: 0pt">673</td><td style="padding: 0pt; width: 1%; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt; text-align: left; text-indent: 0pt">Revenue recognized that was included in the contract liability balance at the beginning of the year</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">(141</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">)</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-align: right; text-indent: 0pt">(593</td><td style="padding: 0pt; text-align: left; text-indent: 0pt">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt; text-indent: 0pt">Additions</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt">106</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; border-bottom: Black 1.5pt solid; text-align: right; text-indent: 0pt">568</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding: 0pt; text-align: left; text-indent: 0pt">Remaining performance obligations</td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; text-align: right; text-indent: 0pt">613</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td><td style="padding: 0pt; text-indent: 0pt"> </td> <td style="padding: 0pt; border-bottom: Black 4pt double; text-align: left; text-indent: 0pt">$</td><td style="padding: 0pt; border-bottom: Black 4pt double; text-align: right; text-indent: 0pt">648</td><td style="padding: 0pt; text-align: left; text-indent: 0pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 74.7pt; text-align: left"> </p>
CY2023Q1	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	648000	usd
CY2022Q4	asns	Contract With Customer Liability Revenue Recognize ContractWithCustomerLiabilityRevenueRecognize	673000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-141000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-593000	usd
CY2023Q1	asns	Additions Additions	106000	usd
CY2022Q4	asns	Additions Additions	568000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	613000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	648000	usd
CY2023Q1	us-gaap	Purchase Obligation PurchaseObligation	613	usd
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	76000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	80000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	548000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	726000	usd
CY2023Q1	asns	Revenues Percentage RevenuesPercentage	0.10	pure
CY2017Q1	us-gaap	Convertible Debt ConvertibleDebt	26	usd
CY2022Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	59200	shares
CY2022Q4	asns	Directors Shares Transaction DirectorsSharesTransaction	10000	shares
CY2023Q1	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.07	pure
CY2023Q1	asns	Accountable Non Expenses AccountableNonExpenses	65000	usd
CY2023Q1	us-gaap	Property Management Fee Percent Fee PropertyManagementFeePercentFee	0.01	pure
CY2023Q1	asns	Unregistered Warrants Purchase Percentage UnregisteredWarrantsPurchasePercentage	0.07	pure
CY2023Q1	asns	Purchase Of Common Stock PurchaseOfCommonStock	66127	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.6313
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ACTELIS NETWORKS INC
CY2023Q1	asns	Common Stock Value1 CommonStockValue1		usd
CY2022Q4	asns	Common Stock Value1 CommonStockValue1		usd
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2022Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2022Q1	asns	Short Term Restricted Bank Deposits ShortTermRestrictedBankDeposits		usd
CY2022Q1	asns	Long Term Restricted Bank Deposits LongTermRestrictedBankDeposits		usd
CY2022Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue		usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs		usd
CY2022Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P3Y
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2023Q1	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment		usd
CY2023Q1	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount		usd
CY2022	us-gaap	Additions To Other Assets Amount AdditionsToOtherAssetsAmount		usd
CY2023Q1	asns	Conversion To The Companys Common Stock ConversionToTheCompanysCommonStock		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	asns	Share Based Compensation Arrangement By Share Based Payment Options Grants ShareBasedCompensationArrangementByShareBasedPaymentOptionsGrants		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	asns	Share Based Compensation Arrangements Weighted Average Exercise Price ShareBasedCompensationArrangementsWeightedAverageExercisePrice		shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001141284

Files In Submission

Name	View Source	Status
0001213900-23-038739-index-headers.html	Edgar Link	pending
0001213900-23-038739-index.html	Edgar Link	pending
0001213900-23-038739.txt	Edgar Link	pending
0001213900-23-038739-xbrl.zip	Edgar Link	pending
asns-20230331.xsd	Edgar Link	pending
f10q0323ex31-1_actelis.htm	Edgar Link	pending
f10q0323ex31-2_actelis.htm	Edgar Link	pending
f10q0323ex32-1_actelis.htm	Edgar Link	pending
f10q0323ex32-2_actelis.htm	Edgar Link	pending
f10q0323_actelisnetworks.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
asns-20230331_cal.xml	Edgar Link	unprocessable
asns-20230331_def.xml	Edgar Link	unprocessable
asns-20230331_lab.xml	Edgar Link	unprocessable
asns-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_actelisnetworks_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ASNS
ACTELIS NETWORKS INC Stock $asns

2023 Q2 Form 10-Q Financial Statement

#000121390023038739 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS ACTELIS NETWORKS INC Stock $asns

2023 Q2 Form 10-Q Financial Statement

#000121390023038739 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ASNS
ACTELIS NETWORKS INC Stock $asns